Cite
HARVARD Citation
Sun, H. et al. (2018). Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection. Gut. 67 (7), pp. 1342-1350. [Online].